unresectable cutaneous melanoma
Showing 1 - 5 of 5
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Recruiting
- Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +26 more
- Biopsy
- +5 more
-
Newark, Delaware
- +52 more
Feb 2, 2023
Unresectable Cutaneous Melanoma, Metastatic Cutaneous Melanoma Trial in Worldwide (Sintilimab + IBI110)
Withdrawn
- Unresectable Cutaneous Melanoma
- Metastatic Cutaneous Melanoma
- Sintilimab + IBI110
-
San Francisco, California
- +12 more
Nov 16, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +20 more
- Neoantigen Peptide Vaccine
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 7, 2022
Advanced Melanoma, Melanoma of Unknown Primary, Mucosal Melanoma Trial in United States (Ipilimumab, Nivolumab)
Active, not recruiting
- Advanced Melanoma
- +10 more
- Ipilimumab
- Nivolumab
-
Anchorage, Alaska
- +638 more
Aug 30, 2022
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in United
Active, not recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +4 more
- Biospecimen Collection
- +9 more
-
Birmingham, Alabama
- +848 more
Aug 24, 2022